DALLAS, TX, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Titanium Healthcare, Inc. (OTCQB:TIHC) a diversified and innovative healthcare ancillaries and life sciences company, announced its approval of accreditation status by Accreditation Commission for Health Care ("ACHC") for the services of non-sterile compound of patient specific prescriptions. This accreditation was achieved for Titanium's wholly-owned subsidiary, Preferred RX based in Arlington, Texas.
"Achieving accreditation is a process where healthcare organizations demonstrate compliance with national standards. Accreditation by ACHC reflects our dedication and commitment to meeting standards that facilitate a higher level of performance and patient care now and for years to come," said Chris Mashburn, Chief Operating Officer and Interim Co-CEO.
ACHC is a not-for-profit organization that has stood as a symbol of quality and excellence since 1986. ACHC is ISO 9001:2008 certified and has Center for Medicare and Medicaid Services Deeming Authority for Home Health, Hospice and Durable Medical Equipment, Prosthetics, Orthotics and Supplies. The ACHC accreditation of Titanium Healthcare provides assurance that clinical care processes and business processes are best-in-class. The standards focus on patient safety, organizational excellence and quality improvement, elements that Titanium has met and has goals to surpass in a continued effort to improve the healthcare industry.
"We are proud of our accreditation team led by John Helfrich (Pharmacist-In-Charge), Jeremy Smith (Manager of Organizational Development), and Jason Evans (V.P. of Information Services); who excelled through completing the preparation and accreditation process in under three months while maintaining the highest levels of patient service throughout," said Mr. Mashburn.
"We are thrilled to have earned this accreditation in addition to our existing 47 state pharmacy licenses, and with this we have become one of the few accredited compounding pharmacies in the nation," said Mr. Mashburn. "This will not only open new avenues to us for reaching organizational goals, but also furthers our ability to provide outstanding products and services to our providers and patients."
Titanium Healthcare, Inc. is a diversified healthcare ancillaries and life science company focused on improving patients' lives by our "personalized medicine" and "prevention of prescription drug abuse" initiatives which can be accomplished through offering products, services and education. We currently offer personalized medicine products through our owned-pharmacy which can prepare compounded prescription medications, tailored for a patient's treatment plan, and through our pharmacogenomics testing services performed through relationships with third-party labs. We offer compounded prescription pain medications through our pharmacy as an alternative to prescription pain medications, and medication monitoring through our urine drug toxicology testing services performed through relationships with third-party labs. Titanium's business plan is to consolidate a fragmented healthcare industry through mergers and acquisitions. For more information, please visit www.titaniumhc.com.
CONTACT: Investor Relations: Chief Financial Officer, Chuck Talley firstname.lastname@example.org Media Contact: Chris Mashburn Titanium Healthcare, Inc. email@example.com http://titaniumhc.com Source:Titanium Healthcare, Inc.